• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Thomson Scientific Identifies the Effects of Marine Toxins on Human Health and Use of High-Dose Therapy to Treat Bone Marrow Cancer As Hot Areas of Research

Posted on: Monday, 28 November 2005, 09:00 CST

PHILADELPHIA and LONDON, Nov. 28 /PRNewswire-FirstCall/ -- Health effects on humans from Florida red tides and related marine toxins, and high-dose therapy treatments of bone marrow cancer are up-and-coming areas of research, according to the Thomson Scientific Essential Science Indicators(SM) (ESI) Special Topics Website. The site provides citation analyses and commentary for research areas that have experienced notable recent advances or are of special current interest. Thomson Scientific is a business of The Thomson Corporation Toronto.

Every two months, Thomson Scientific specialists identify emerging and fast-breaking "Research Fronts" - areas of scientific research that gain particular attention, and "Hot and Fast Breaking Papers" - individual papers that achieve a rate of citations that is markedly higher than papers of comparable type and age.

Below are some highlights from the October/November ESI Special Topics Website content.

Emerging Research Front - Measuring a Red Tide's Effects on Humans

Multiple studies have shown that when marine toxins are ingested, most commonly through eating affected shellfish, they cause illness in humans, such as neurotoxic shellfish poisoning (NSP). In a highly cited paper that leads October's Emerging Research Front, co-author Lorraine C. Backer's research group addresses in depth the health effects, such as NSP, caused from environmental exposure to marine toxins, or brevetoxins, associated with red tides, or harmful algal bloomings.

To read the complete interview with this author, visit: http://www.esi-topics.com/erf/2005/october05-LorraineCBacker.html.

Fast-Moving Front - The Effects of High-dose Therapy on Myeloma

Identified as a November "Fast-Moving Front," recent studies on the effects of high-dose therapy to treat multiple myeloma, a cancer of the plasma cells, have garnered significant attention from the scientific community. One such highly cited paper, "Results of high-dose therapy for 1,000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities," leads this fast-moving front. Co- author Dr. Bart Barlogie explains the impact of his group's research in clinical medicine and, in particular, the importance of "knowing the enemy."

To read the complete interview with this author, visit: http://www.esi-topics.com/fmf/2003/may03-BartBarlogie.html.

Hot Paper - Predicting Climate Changes to Protect the Economy

"There is an increasing demand for climate predictions at different time scales," according to Francisco J. Doblas-Reyes and Tim N. Palmer, co-authors of "Development of a European multimodel ensemble system for seasonal-to- interannual prediction.""Examples of this are monthly forecasts for emergency plans to reduce the impact of warm or cold spells, seasonal forecasts to cope with the remote effects caused by El Nino or La Nina events," and many more. Reyes and Palmer's paper - November's Geosciences "Hot Paper" - describes a methodology to create skillful forecasts of seasonal climate and climate-related variables.

To read the complete interview with these authors, visit: http://www.esi-topics.com/fbp/2005/october05-Doblas-Reyes.html.

Fast Breaking Paper - "Bringing Order" to the Viral Universe

"In the past, viruses have been seen as complicated things placed apart from other organisms by the view that they are not living," said the authors of October's Molecular Biology and Genetics fast-breaking paper, "Does common architecture reveal a viral lineage spanning all three domains of life?""Historically, viruses have often been grouped and studied in terms of disease. These factors make viruses somehow 'strange' and contribute to the difficulty of placing them in an evolutionary context."

The authors, Roger M. Burnett, Ph.D., Stacy D. Benson, Ph.D., Jaana K.H. Bamford, Ph.D., and Dennis H. Bamford, Ph.D., feel their paper has received significant attention because it promises to bring "order" to the viral universe.

To read the complete interview with these authors, visit: http://www.esi-topics.com/fbp/2005/october05-RogerMBurnett.html.

For more information on the Research Fronts Methodology, visit http://www.esi-topics.com/RFmethodology.html.

About the Thomson Corporation

The Thomson Corporation (http://www.thomson.com/), with 2004 revenues of $8.10 billion, is a global leader in providing integrated information solutions to business and professional customers. Thomson provides value- added information, software tools and applications to more than 20 million users in the fields of law, tax, accounting, financial services, higher education, reference information, corporate e-learning and assessment, scientific research and healthcare. With operational headquarters in Stamford, Conn., Thomson has approximately 38,000 employees and provides services in approximately 130 countries. The Corporation's common shares are listed on the New York and Toronto stock exchanges Toronto.

Thomson Scientific is a business of The Thomson Corporation. Its information solutions assist professionals at every stage of research and development - from discovery to analysis to product development and distribution. Thomson scientific information solutions can be found at http://www.scientific.thomson.com/.

Thomson Scientific

CONTACT: Rodney Yancey, Manager, Corporate Communications, ThomsonScientific, +1-215-386-0100 extension 1396, rodney.yancey@thomson.com; orChris Lukach, Anne Klein & Associates, +1-856-988-6560 extension 15,chris@mail.akleinpr.com

Web site: http://www.scientific.thomson.com/http://www.thomson.com/

Source: PRNewswire-FirstCall

More News in this Category